Evaluation of the Efficacy of Injections of Botulinic Toxin in Plantar Lesions of Patients Suffering From Localized Epidermolysis Bullosa Simplex : Double Blind Randomized Controlled Study.
Phase of Trial: Phase II/III
Latest Information Update: 31 Dec 2018
Price : $35 *
At a glance
- Drugs Botulinum toxin (Primary)
- Indications Epidermolysis bullosa
- Focus Therapeutic Use
- Acronyms EBTox
- 18 Dec 2018 Planned End Date changed from 6 Jun 2019 to 1 Jun 2020.
- 18 Dec 2018 Planned primary completion date changed from 6 Jun 2019 to 1 Jun 2020.
- 18 Dec 2018 Status changed from not yet recruiting to recruiting.